Table 1. Distribution of the primary study cohort (n = 10,139) by age, PSA at presentation, biopsy grade, and clinical stage.

Clinico-pathological Characteristic	n
Age (y)
<60	1,121
60–69	3,717
70–79	4,012
≥ 80	1,289
PSA (ng/ml)
<10	4,118
10–20	3,306
>20	2,715
Biopsy grade/ISUP prognostic score
≤3 + 3/prognostic score 1	3,411
3 + 4/prognostic score 2	2,991
4 + 3/prognostic score 3	1,503
8/prognostic score 4	1,004
9–10/prognostic score 5	1,230
Stage
T1	5,452
T2	3,226
T3	1,384
T4	77